A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2006
12/14/2006	WO2006132251A1 Prophylactic/therapeutic agent for adult t cell leukemia
12/14/2006	WO2006132245A1 Tumor growth inhibitor
12/14/2006	WO2006132205A1 Radical scavenger and active oxygen eliminating agent
12/14/2006	WO2006131874A2 Methods for treatment or prophylaxis of atherosclerosis and reperfusion injury
12/14/2006	WO2006131730A1 Glp-1 analogue formulations
12/14/2006	WO2006131722A1 Stem cells and isolation method
12/14/2006	WO2006131586A1 Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
12/14/2006	WO2006131515A2 Stabilised il-21 compositions
12/14/2006	WO2006131512A2 Anti-thrombotic agents
12/14/2006	WO2006131347A2 Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
12/14/2006	WO2006130974A1 Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
12/14/2006	WO2006108586A3 Polymyxin b analogs for lps detoxification
12/14/2006	WO2006105912A3 Peptides that down regulate the activity of plasma membrane transporters including sodium-d-glucose cotransporter sglt1
12/14/2006	WO2006103452A3 Improved nitroreductase enzymes
12/14/2006	WO2006096565A3 Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions
12/14/2006	WO2006094673A3 Synergistic mixtures of c6- to c12-alkanedi0ls and tropolone (derivatives)
12/14/2006	WO2006092106A3 Combination of egf/ghrp-6 for neurogeneration of central nervous system
12/14/2006	WO2006089211A3 Combat/training antioxidant micronutrient formulation and method of administration
12/14/2006	WO2006087550A8 Amyloid-binding peptides, analogues and uses thereof
12/14/2006	WO2006078274A3 Beta-peptides
12/14/2006	WO2006076342A3 Method and system for treating heart failure
12/14/2006	WO2006075932A3 Remedy to accelerate healing of wound and burn
12/14/2006	WO2006074409A9 Tripeptide and tetrapeptide sulfones
12/14/2006	WO2006071469A3 Modulation of the neuroendocrine system as a therapy for amyotrophic lateral sclerosis
12/14/2006	WO2006062935A3 Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin
12/14/2006	WO2006055973A3 Erythropoietin for treatment of multi-organ failure
12/14/2006	WO2006031376A3 Use of antioxidants for treating degenerative disc disease
12/14/2006	WO2006017355A3 Improved aprotinin variants
12/14/2006	WO2006014552A3 Cyclic peptides for treatment of cachexia
12/14/2006	WO2006007444A3 CaMKII/CALCIUM CHANNEL BINDING-RELATED COMPOSITIONS AND METHODS
12/14/2006	WO2005115444A3 Compositions with modified nucleases targeted to viral nucleic acids and methods of use for prevention and treatment of viral diseases
12/14/2006	WO2005095592A3 Subtilase variants having altered immunogenicity
12/14/2006	WO2005079390A3 Inhibition of fgf signaling
12/14/2006	WO2004108069A3 Compositions and methods for promoting neuronal outgrowth
12/14/2006	WO2004101751A3 A modified rubisco large subunit ∈n-methyltransferase useful for targeting molecules to the active-site vicinity of ribulose-1, 5-bisphosphate
12/14/2006	WO2004006861A3 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease
12/14/2006	WO2001022972A9 Immunostimulatory nucleic acids
12/14/2006	US20060282909 Methods and compositions for therapeutic intervention in cardiac hypertrophy
12/14/2006	US20060282908 Identification of the genetic determinants of the polymorphic CYP3A5 expression
12/14/2006	US20060282123 Electrical devices and anti-scarring agents
12/14/2006	US20060282062 Methods and systems for neural maintenance and regeneration
12/14/2006	US20060281905 Crystallization of IGF-1
12/14/2006	US20060281903 Process for producing albumin preparation
12/14/2006	US20060281902 Human signal peptide-containing proteins
12/14/2006	US20060281898 Method for the production of plant seed with modified fibre content and modified seed coat
12/14/2006	US20060281887 (Meth)acrylate copolymer for use as medical carrier
12/14/2006	US20060281813 Methods of treating hyperproliferative cell disorders
12/14/2006	US20060281712 Pyrimidine compounds
12/14/2006	US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins
12/14/2006	US20060281698 a single-stranded antisense oligonucleotide, targeted to nucleic acid encoding lipid-free protein constituents of plasma lipoproteins, used for diagnosis and therapy of cardiovascular disorders, including myocardial infarction and atherosclerosis
12/14/2006	US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia
12/14/2006	US20060281696 Decoy-oligonucleotide-inhibition of cd40-expression
12/14/2006	US20060281690 Crystalline (2E,4S)-4-[(N-{[(2R)-1-isopropylpiperidin-2-yI]-carbonyl}-3-methyl-L-valyl)(methyl)amino]-2,5-dimethylhex-2-enoic acid and its pharmaceutical uses
12/14/2006	US20060281689 Method for modulating activity of HCV protease through use of a novel HCV protease inhibitor to reduce duration of treatment period
12/14/2006	US20060281688 Administration of HCV protease inhibitors in combination with food to improve bioavailability
12/14/2006	US20060281687 Cyclin groove inhibitors
12/14/2006	US20060281686 Aza-peptides
12/14/2006	US20060281685 biodrug as antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer
12/14/2006	US20060281684 Peptide dimer(s) whose structure is maintained by a pair of disulfide bonds between two cystein residues, which does not exceed 17 amino acids and has cationic and hydrophobic amino acid residues; noncovalently binds the lipopolysaccharide of Gramnegative bacteria with high affinity
12/14/2006	US20060281683 Branched cationic copolymers and methods for antimicrobial use
12/14/2006	US20060281682 Methods and compositions for the treatment of gastrointestinal disorders
12/14/2006	US20060281681 Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease
12/14/2006	US20060281680 Methods and compositions for modulating vascular integrity
12/14/2006	US20060281679 Human FGF-23 gene and gene expression products
12/14/2006	US20060281678 Novel inhibitor of angiogenesis, tumor progression, and metastasis targeting ras signalling pathway
12/14/2006	US20060281677 Compositions and methods for intracellular delivery of biotinylated cargo
12/14/2006	US20060281676 Agent and method for the treatment and prevention of tse and method for the production of said agent
12/14/2006	US20060281675 Somatogenic therapy using a 20kda placental variant of growth hormone
12/14/2006	US20060281674 Reducing the risk of infection in a patient with lowered neutrophil count byadministering an immunostimulant S100 protein; immunosuppressed, chemotherapy-treatedpatients and those having bone marrow transplant; measurement of neutrophil bloodconcentrations; side effect reduction; cost efficiency
12/14/2006	US20060281673 Novel peptide inhibitor of hiv fusion that disrupts the internal trimeric coiled-coil of gp41
12/14/2006	US20060281672 Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof
12/14/2006	US20060281671 Organic compounds
12/14/2006	US20060281670 Compositions and methods for modulating angiogenesis
12/14/2006	US20060281669 Method and compositions for the treatment of diabetes and related complications
12/14/2006	US20060281668 Vascular disease therapies
12/14/2006	US20060281667 Cardiovascular disease therapies
12/14/2006	US20060281179 Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof
12/14/2006	US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
12/14/2006	US20060281149 Transforming growth factor-beta-related molecules and uses thereof
12/14/2006	US20060281146 Novel compositions and methods for the treatment of immune related diseases
12/14/2006	US20060281130 Metod of modulation of interaction between receptor and ligand
12/14/2006	US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006	US20060281095 44 human secreted proteins
12/14/2006	US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006	US20060281072 Stimulation of human T-cells and used to enhance antigen-specific immune responses; immunotherapy
12/14/2006	US20060280812 Compositions and methods for the treatment of muscular dystrophy
12/14/2006	US20060280804 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis
12/14/2006	US20060280802 Therapeutic uses of beta-casein a2 and dietary supplement containing beta-casein a2
12/14/2006	US20060280782 Dermal delivery system composition comprising an aqueous base vehicle including Emu oil, at least one fatty acid alkyl ester, polyethylene glycol, and a gelling agent, in combination with a therapeutically effective amount of at least one species of insulin
12/14/2006	US20060280780 Antimicrobial polypeptides
12/14/2006	US20060280769 Terminal sterilization of injectable collagen products
12/14/2006	US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
12/14/2006	US20060280742 monoclonal antibody for treating cancer, neovascularization, vascular and arthritic diseases; immunoassay; immunotherapy; inhibition or antagonism of TNF decreases expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF); decrease angiogenesis
12/14/2006	US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis
12/14/2006	US20060280739 Novel human beta-2 integrin alpha subunit
12/14/2006	US20060280738 Anti-CD19 antibody therapy for transplantation
12/14/2006	US20060280737 Reducing body weight or food intake ; binding to antibody
12/14/2006	US20060280731 Novel substrate for Rpn11 enzymatic activity
12/14/2006	US20060280730 Induction of apoptosis of malignant cells by activation of calcium-activated potassium channels
12/14/2006	US20060280723 Interferon for treating or preventing a coronaviral infection

1 ... 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 ... 3163